WHO grants prequalification of Actemra/RoActemra for patients with severe or critical COVID-19 February 11, 2022February 22, 2022 by / Share This.....LinkedinTwitterFacebookGoogleEmailRelated News: WHO grants prequalification of Actemra/RoActemra for…CHMP recommends EU approval of Actemra/RoActemra to…Actemra/RoActemra approved by the European…U.S. FDA grants priority review to Roche’s…New data reinforce the benefit of early preventative…Roche enters partnership with the Global Fund to…
